Weizman Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 12.77%
- Profit Growth -11.49%
- Ebitda 9.02%
- Net Worth 33.19%
- Total Assets 99.85%
About Weizman Pharmaceuticals
Weizman Pharmaceuticals Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 December 2018 (Six years and one month 11 days old ). Its registered office is in Bahraich, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Zameer Ahmad and Sadqa Farheen serve as directors at the Company.
Company Details
- Location
Bahraich, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909UP2018PTC111424
- Company No.
111424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2018
- Date of AGM
22 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Weizman Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zameer Ahmad  | Director | 18-Dec-2018 | Current |
| Sadqa Farheen | Director | 18-Dec-2018 | Current |
Financial Performance of Weizman Pharmaceuticals.
Weizman Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.77% increase. The company also saw a substantial fall in profitability, with a 11.49% decrease in profit. The company's net worth Soared by an impressive increase of 33.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Weizman Pharmaceuticals?
Unlock access to Weizman Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Weizman Pharmaceuticals?
Unlock and access historical data on people associated with Weizman Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Weizman Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Weizman Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.